General MedicationsTOPICALStandard
ERTACZO
SERTACONAZOLE NITRATE
Standard Dose
2%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview ERTACZO is listed in Drugs@FDA under application 021385 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient SERTACONAZOLE NITRATE Form and strength CREAM;TOPICAL - 2% Sponsor LACER PHARMA Submission history Latest submission status date: 2020-12-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview ERTACZO is listed in Drugs@FDA under application 021385 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SERTACONAZOLE NITRATE Form and strength CREAM;TOPICAL - 2% Sponsor LACER PHARMA Submission history Latest submission status date: 2020-12-17 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.